Profile
Artenga’s microbubble drug conjugates (MDC) are used with focused ultrasound (FUS) as a key enabler for:
- Safe, non-invasive, targeted blood brain barrier drug delivery
- Boosting immunotherapy efficacy without added toxicity
Our Sunnybrook collaborators did first in human FUS and (non-drug loaded) microbubble BBB opening for glioblastoma, Alzheimer’s, breast cancer brain mets, and ALS.
Artenga’s differentiation:
- Higher dose delivered with greater perfusion
- Liver clearance of unused drug to mitigate systemic effects
- AAV gene therapy MDC and technology to prevent peripheral dosing

Website
artenga.comContact
-
James Keenan, Chief Executive OfficerTel: +1 613-322-8585Email: jkeenan@artenga.com
Event details
Date: September 14 - 16, 2020
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
16 in total
-
Artenga’s microbubble drug conjugates (MDC) are used with focused ultrasound (FUS) as a key…
-
ChipCare is a Toronto-based pre-revenue company, developing a point-of-care platform which will have the unique…
-
Curiato is pioneering a non-invasive patient monitoring platform for healthcare. Our platform relies on our smart bed…
-
Exact Imaging is the world’s leader in high-resolution micro-ultrasound systems enabling real-time imaging and guided…
-
KA Imaging has created color x-ray that allows for bone and soft tissue separation similar to CT, but at a fraction of…
-
The low-cost Lumasonix Blood Test (LBT) provides crucial information about otherwise undetectable cancer…
-
Mediphage Bioceuticals is a genetic medicine company developing safe, effective, and accessible cures for chronic and…
-
Nanology Labs has developed a tumor modulating theranostic agent, Manganescan, with capability to oxygenate tumors and…
-
OPTT is a digital mental health platform equipping healthcare organizations with a comprehensive package of digital…
-
Ovensa is a Canadian preclinical stage company developing a siRNA drug candidate silencing the overexpression of…
-
SaluTech has developed a proprietary conductive biomaterial (CBM) to treat patients suffering from Atrial…
-
The SWANglide ultrasound-enhanced needle biopsy from Swan Cytologics improves patient outcomes and reduces healthcare…
-
Thornhill Medical is a Canadian designer and manufacturer of innovative healthcare technology. Our product portfolio…
-
Ventripoint Diagnostics is a medical device company engaged in the development and commercialization of a breakthrough…
-
VeriLuce Therapeutics is an early-stage company currently focusing on the computational design and development of small…
-
Vitreo Pharma is a developmental stage company that utilizes a polypharmacology strategy to generate our lead, first-in…